SCHEMBL7063150

SCHEMBL7063150

NCCCN1CCN(CCCNc2cccc3c2C(=O)c2ccccc2C3=O)CC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.53
NPSR1 Q6W5P4 2/20 0.53
MEN1 O00255 2/20 0.53
POLB P06746 2/20 0.53
KMT2A Q03164 2/20 0.53
EGFR P00533 2/20 0.53
MAPK1 P28482 2/20 0.53
SMN1; SMN2 Q16637 2/20 0.53
L3MBTL1 Q9Y468 2/20 0.53
ALDH1A1 P00352 1/20 0.53
LMNA P02545 1/20 0.53
HTT P42858 1/20 0.53
RAD52 P43351 1/20 0.53
RECQL P46063 1/20 0.53
BLM P54132 1/20 0.53
NQO1 P15559 1/20 0.50
MALT1 Q9UDY8 1/20 0.48
NSD2 O96028 1/20 0.48
FGB P02675 1/20 0.48
MMP14 P50281 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL109325 0.86 MEN1 (0.64) MAPTNPSR1MEN1POLBKMT2A
SCHEMBL8602072 0.84 MAPT (0.63) MAPTNPSR1MEN1POLBKMT2A
Hydrochloric Acid SCHEMBL6577424 0.84 MAPT (0.63) MAPTNPSR1MEN1POLBKMT2A
SCHEMBL11688654 0.83 TERT (0.61) MAPTNPSR1MEN1POLBKMT2A
Hydrochloric Acid SCHEMBL8603274 0.83 MAPT (0.61) MAPTNPSR1MEN1POLBKMT2A
SCHEMBL32667983 0.83 MAPT (0.61) MAPTNPSR1MEN1POLBKMT2A
SCHEMBL8601416 0.83 MAPT (0.61) MAPTNPSR1MEN1POLBKMT2A
Hydrochloric Acid SCHEMBL8604068 0.82 MAPT (0.60) MAPTNPSR1MEN1POLBKMT2A
SCHEMBL20334284 0.81 NSD2 (0.63) MAPTNPSR1MEN1POLBKMT2A
SCHEMBL11689938 0.81 NQO1 (0.65) MAPTNPSR1MEN1POLBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030130272-A1 Anthracene derivatives as anti-cancer agents BTG INTERNATIONAL LIMITED (GB) 2003-07-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030130272-A1 Anthracene derivatives as anti-cancer agents TOP2B, TOP1, TOP2A MAPT 4884/4885NPSR1 4131/4885MEN1 3649/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.